🇺🇸 FDA
Patent

US 12404317

T cell receptors recognizing MHC class II-restricted MAGE-A3

granted A61KA61K2039/585A61K38/1774

Quick answer

US patent 12404317 (T cell receptors recognizing MHC class II-restricted MAGE-A3) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/585, A61K38/1774, A61K39/0005, A61P